Prospective Evaluation of Risk Factors for Bloodstream Infection in Patients Receiving Home Infusion Therapy
- 7 September 1999
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 131 (5) , 340-347
- https://doi.org/10.7326/0003-4819-131-5-199909070-00004
Abstract
Intravenous therapy in the outpatient and home settings is commonplace for many diseases and nutritional disorders. Few data are available on the rate of and risk factors for bloodstream infection among patients receiving such therapy. To determine rates of and risk factors for bloodstream infection among patients receiving home infusion therapy. Prospective, observational cohort study. Cleveland, Ohio, and Toronto, Ontario, Canada. Patients receiving home infusion therapy through a central or midline catheter. Primary laboratory-confirmed bloodstream infection. Among 827 patients (988 catheters), the most common diagnoses were infections other than HIV (67%), cancer (24%), nutritional and digestive disease (17%), heart disease (14%), receipt of bone marrow or solid organ transplants (11%), and HIV infection (7%). Sixty-nine bloodstream infections occurred during 69 532 catheter-days (0.99 infections per 1000 days). In a Cox regression model with time-dependent covariates, independent risk factors for bloodstream infection were recent receipt of a bone marrow transplant (hazard ratio, 5.8 [95% CI, 3.0 to 11.3]), receipt of total parenteral nutrition (hazard ratio, 4.1 [CI, 2.3 to 7.2]), receipt of therapy outside the home (for example, in an outpatient clinic or physician's office) (hazard ratio, 3.6 [CI, 2.2 to 5.9]), use of a multilumen catheter (hazard ratio, 2.8 [CI, 1.7 to 4.7]), and previous bloodstream infection (hazard ratio, 2.5 [CI, 1.5 to 4.2]). Rates of bloodstream infection per 1000 catheter-days varied from 0.16 for patients with none of these 5 risk factors to 6.77 for patients with 3 or more risk factors. Centrally inserted venous catheters were associated with a higher risk than implanted ports were, but the difference was not statistically significant. Bloodstream infections seem to be infrequent among outpatients receiving infusions through central and midline catheters. However, the rate of infection increases with bone marrow transplantation, parenteral nutrition, infusion therapy in a hospital clinic or physician's office, and use of multilumen catheters. Compared with implanted ports or peripherally inserted catheters, centrally inserted venous catheters may confer greater risk for bloodstream infection.Keywords
This publication has 19 references indexed in Scilit:
- National Nosocomial Infections Surveillance (NNIS) Report, data summary for October 1986–April 1997, issued May 1997American Journal of Infection Control, 1997
- Peripherally Inserted Central Catheters in General MedicineMayo Clinic Proceedings, 1997
- Bloodstream infections in home infusion patients: The influence of race and needleless intravascular access devicesThe Journal of Pediatrics, 1996
- NOSOCOMIAL COAGULASE-NEGATIVE STAPHYLOCOCCAL INFECTIONS IN BONE MARROW TRANSPLANTATION RECIPIENTS WITH CENTRAL VEIN CATHETERTransplantation, 1996
- Departmental role and scope in infection conrol: Use of a template that meets joint commission requirementsAmerican Journal of Infection Control, 1996
- New Hope for Home Care?New England Journal of Medicine, 1995
- From the Health Care Financing AdministrationJAMA, 1994
- Infectious Morbidity Associated with Long-Term Use of Venous Access Devices in Patients with CancerAnnals of Internal Medicine, 1993
- Single- versus triple-lumen central catheter-related sepsis: A prospective randomized study in a critically ill populationThe American Journal of Medicine, 1992
- Infections associated with hickman catheters in patients with acquired immunodeficiency syndromeThe American Journal of Medicine, 1989